Effects of Blood Flow Restriction Training on Muscle Strength and Physical Function for Stroke-Related Sarcopenia
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · May 7, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special exercise method called Blood Flow Restriction (BFR) walking on muscle strength and physical function in patients who have had a stroke and are experiencing muscle loss, known as sarcopenia. The main goal is to see if BFR walking can help improve the strength of muscles and overall physical abilities compared to a sham (placebo) version of BFR walking. Additionally, the study will look at how this type of exercise might affect muscle size, blood vessel health, and quality of life for these patients.
To be eligible for this trial, participants must have had a stroke at least six months ago and be diagnosed with sarcopenia. However, those who had a stroke within the last six months or have certain health issues, like very high blood pressure or implanted devices that could interfere with the study, will not be able to join. Participants can expect to take part in walking exercises using BFR techniques, and the study will help determine if this approach can effectively support recovery and improve their daily lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with chronic stroke (≥6 months post-stroke)
- • Diagnosed with sarcopenia, based on AWGS 2019 criteria
- Exclusion Criteria:
- • Stroke occurred within the past 6 months
- • Resting systolic blood pressure \> 200 mmHg
- • Resting diastolic blood pressure \> 100 mmHg
- • Presence of implanted electronic or metallic devices that interfere with blood flow restriction cuffs
- • Contraindication to bioelectrical impedance analysis (e.g., pacemaker, ICD)
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hung Hom, Kowloon, Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported